These final results, along with a past report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 support the strategy of concentrating on ACKR3 as a unique solution to modulate the opioid procedure, which could open new therapeutic avenues for opioid-connected Diseases. The website is protected. https://salvadorm235bri6.mybuzzblog.com/profile